Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
story of the week
Published in Oncology and
1 other channel

Journal Scan / Research · October 15, 2023

Dabrafenib Plus Trametinib for Pediatric Glioma With BRAF V600 Mutations

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

The New England Journal of Medicine
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
N. Engl. J. Med 2023 Sep 21;389(12)1108-1120, E Bouffet, JR Hansford, ML Garrè, J Hara, A Plant-Fox, I Aerts, F Locatelli, J van der Lugt, L Papusha, F Sahm, U Tabori, KJ Cohen, RJ Packer, O Witt, L Sandalic, A Bento Pereira da Silva, M Russo, DR Hargrave

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading

Most Read This Week

Recently Updated